Obesity and Air Pollution: Global Risk Factors for Pediatric Non-alcoholic Fatty Liver Disease by Kelishadi, Roya & Poursafa, Parinaz
KOWSAR
Journal home page: www.HepatMon.com
Obesity and Air Pollution: Global Risk Factors for Pediatric Non-alco-
holic Fatty Liver Disease
 Roya  Kelishadi 1,2,   Parinaz Poursafa 3,4 *
1  Pediatrics Department, Child Health Promotion Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran 
2  Pediatrics Department, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran 
3  Department of Environment and Energy, Science and Research Branch, Islamic Azad University, Tehran, IR Iran 
4  Environment Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran
* Corresponding author: Parinaz Poursafa, Department of Environment 
and Energy, Science and Research Branch, Islamic Azad University, Teh-
ran, IR Iran. Tel: +98-2144865100 Fax: +98-2144865154, E-mail: parinaz.
poursafa@gmail.com
DOI: 10.5812/kowsar.1735143X.746
Copyright  c 2011, BRCGL, Published by Kowsar M.P.Co.  All rights reserved.
ARTICLE INFO ABSTRACT
Article history:
Received: 12 Jun 2011
Revised: 14 Jul 2011
Accepted: 25 Jul 2011
Keywords:
 Fatty  Liver
 Child
 Obesity
 Environmental  Exposure
  Prevention and Control
 Air  Pollution
Article type:
Review Article
  Please cite this paper as: 
Kelishadi R, Poursafa P. Obesity and Air Pollution: Global Risk Factors for Pediatric Non-alcoholic Fatty Liver Disease. Hepat Mon. 
2011;11(10):794-802. DOI: 10.5812/kowsar.1735143X.746
 Implication for health policy/practice/research/medical education:
Nonalcoholic fatty liver disease (NAFLD) is becoming as an important health problem for children and adolescents.In addition to 
excess weight, the role of environmental factors, as smoking and air pollution should be considered in this regard. This study is 
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Non-alcoholic fatty liver disease (NAFLD) is becoming as an important health problem in 
the pediatric age group. In addition to the well-documented role of obesity on the fatty 
changes in liver, there is a growing body of evidence about the role of environmental 
factors, such as smoking and air pollution, in NAFLD. Given that excess body fat and ex-
posure to air pollutants is accompanied by systemic low-grade inﬂammation, oxidative 
stress, as well as alterations in insulin/insulin-like growth factor and insulin resistance, 
all of which are etiological factors related to NAFLD, an escalating trend in the incidence 
of pediatric NAFLD can be expected in the near future. This review focuses on the current 
knowledge regarding the epidemiology, diagnosis and pathogenesis of pediatric NAFLD. 
The review also highlights the importance of studying the underlying mechanisms of 
pediatric NAFLD and the need for broadening eﬀorts in prevention and control of the 
main risk factors. The two main universal risk factors for NAFLD, obesity and air pollu-
tion, have broad adverse health eﬀects, and reducing their prevalence will help abate the 
serious health problems associated with pediatric NAFLD.
Hepat Mon. 2011;11(10):794-802. DOI: 10.5812/kowsar.1735143X.746
1. Introduction
Non-alcoholic fatty liver disease (NAFLD) is considered 
the most common liver disease in various age groups. 
Its development is strongly linked to obesity (1), as well 
as to the relative changes in body mass index in each in-
dividual, which may be related to the onset of fatty liver 
(2). Even though liver steatosis has various causes in the 
pediatric age group, such as inherited metabolic disor-
ders, malnutrition, infections, and drug toxicity, fatty 
liver disease is often seen in children in the absence of an 
apparent inherited metabolic defect or a speciﬁc cause. 
The vast majority of children with fatty liver disease are 
found to be obese and insulin resistant (1, 2). Low- and 
middle-income countries face the double burden of 
nutritional disorders, with an increasing prevalence of 
childhood obesity (3), and therefore, an increasing num-
ber of reports of NAFLD in the pediatric age group (4-7). 
An increasing number of studies have proposed an asso-
ciation between environmental factors, namely air pollu-
tion, and fatty changes in the liver.  This review will focus 
on the current knowledge regarding the epidemiology, 795
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diagnosis, and pathogenesis of pediatric NAFLD, as well 
as the possible associations with obesity and air pollu-
tion, which are the adverse eﬀects of urbanization and 
globalization of lifestyle.
2. Global Trends in Childhood Obesity 
The World Health Organization states “An escalating 
global epidemic of overweight and obesity– “globesity”–
is taking over many parts of the world” (8). Of special 
concern in the context of this epidemic is the escalating 
trend in the prevalence of childhood overweight and 
obesity on a global scale. There are several reports on the 
increasing prevalence of childhood obesity in industrial-
ized countries (9-14); however, this is an emerging health 
problem in low- and middle-income countries as well 
(15-18). An analysis of 450 nationally representative cross-
sectional surveys of preschool-aged children from 144 
countries indicated that in 2010, 43 million children, 35 
million of them in developing countries, were estimated 
to be overweight and obese, and 92 million were at risk 
of becoming overweight. The global prevalence of child-
hood overweight and obesity increased from 4.2% (95% 
CI: 3.2%, 5.2%) in 1990 to 6.7% (95% CI: 5.6%, 7.7%) in 2010. 
This trend is expected to reach 9.1% (95% CI: 7.3%, 10.9%), 
or ≈60 million, in 2020 (19). It is noteworthy that in many 
cases, the excess weight of children in developing coun-
tries is because of their stunting (15, 20, 21). These ﬁnd-
ings highlight the need for determining the barriers to 
healthy lifestyle (22) and promoting healthy living in 
their current obesogenic environments to reverse the 
anticipated health and social consequences of childhood 
overweight, namely NAFLD.
3. Histological Appearance of Pediatric 
NAFLD 
The spectrum of NAFLD ranges from pure fatty inﬁltra-
tion (steatosis) to inﬂammation non-alcoholic steato-
hepatitis (NASH), ﬁbrosis, and cirrhosis (23). It accounts 
for up to 20% of abnormal liver function test results in 
most developed countries (24). The his    tological appear-
ance of NAFLD diﬀers signiﬁcantly in children and adults; 
it might represent a physiological response to environ-
mental factors in children and a long-standing adapta-
tion in adults. The histological criteria for distinguishing 
between adult (type 1) and pediatric (type 2) NASH have 
been proposed. Prominently, the histological features of 
liver injury seem to be associated with gender- and age-
speciﬁc prevalence, i.e., type 2 NASH is more prevalent in 
younger children, and signiﬁcantly more boys are aﬀect-
ed by type 2 NASH than girls (25). Among obese children, 
the severity of steatosis is found to be associated with in-
creased visceral fat mass, insulin resistance, lower adipo-
nectin levels, and higher blood pressure (26). 
4. Diagnosis of Pediatric NAFLD
4.1. Biochemical Tests 
Liver biopsy is the gold standard for diagnosis, but giv-
en that it is not feasible in large epidemiological studies, 
surrogate markers such as serum alanine/aspartate ami-
notransferases (ALT/AST) or ultrasonography are usually 
used to detect NAFLD (27). The normal range of ALT/AST 
levels varies widely, and biopsy-proven NAFLD has been 
found in children with normal aminotransferase levels 
(25, 28, 29). Aminotransferases, including aspartate AST 
and ALT, are commonly used in evaluating liver patholo-
gies such as NAFLD and hepatitis. Given that AST is pro-
duced in diﬀerent tissues such as the liver, heart, muscle, 
kidney, and brain, ALT has been generally accepted as a 
better predictor of liver injury. Usually in a clinical set-
ting, an ALT level of 40 IU/L is considered the upper limit 
of the normal range (30). However, some studies sug-
gested lower cutoﬀ values in children than in adults (31, 
32). Moreover, some researchers have proposed gender 
diﬀerences for these levels, i.e., 19U/L and 30U/L for girls 
and boys, respectively (33, 34).
4.2. Radiologic Diagnosis 
The image-based diagnosis of NAFLD is usually straight-
forward, but fat accumulation may be manifested with 
unusual structural patterns that simulate other con-
ditions. Fat deposition in the liver may be identiﬁed 
non-invasively with ultrasonography, computerized to-
mography, or magnetic resonance imaging (35, 36). In 
ultrasonography, the echogenicity of the normal liver 
nearly equals or slightly exceeds that of the renal cortex 
or spleen. Intrahepatic vessels are tightly deﬁned, and 
the posterior parts of the liver are well-illustrated. Fatty 
liver may be identiﬁed if liver echogenicity exceeds that 
of the renal cortex and spleen, with attenuation of the 
ultrasound wave, loss of delineation of the diaphragm, 
and poor demarcation of the intrahepatic architecture 
(37, 38).
5. Prevalence of Pediatric NAFLD
Determination of the prevalence of NAFLD accurately 
in children is diﬃcult. Because of the aforementioned 
limitations and controversies in the diagnosis of NAFLD 
in children and adolescents, data based on surrogate 
markers might underestimate or overestimate the cur-
rent burden of pediatric NAFLD. One of the strongest 
population-based studies, using the histologic deﬁni-
tion for NAFLD, was conducted as a retrospective review 
of autopsies, performed from 1993 to 2003 on 742 chil-
dren aged 2 to 19 years. The prevalence of NAFLD was es-
timated as 9.6%, ranging from 0.7% in children aged 2–4 
years, to 17.3% in those aged 15–19 years, with the highest 
documented rate, as high as 38%, in obese children. It is 
of note that this study revealed diﬀerences in terms of 
race and ethnicity in the prevalence of pediatric NAFLD, 
with a prevalence of 11.8% in Hispanics, 10.2% in Asians, 
8.6% in Whites, and 1.5% in Blacks (39). Results from the 
US National Health and Nutrition Examination Survey 
(NHANES 1999–2004) reported a prevalence of 8% for 
NAFLD in adolescents, based on elevated serum ALT (40). 
This prevalence is reported to be much higher among 796
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Location Population Studied Aims Findings
Widhalm et al. 
(2010) (63)
Review Review article To provide a detailed 
review for diagnosis and 
management of NAFLD a 
and NASH
 a
The prevalence ranges from at 
least 3% in children overall to 
about 50% in obese children
Liu et al. 
(2010) (53)
China 231obese children and 
24 non-obese children 
as controls
To compare biochemi-
cal indicators and 
carotid intima-media 
thickness (IMT)
The NAFLD group had greater 
carotid IMT, hyperlipidemia 
and hypertension than other 
groups. IMT correlated with 
BMI, NAFLD and ALT a
Lin et al.
(2010) (52)
Taiwan 69 obese children aged 
6-17 y
To identify biomarkers 
for liver steatosis in 
obese children 
Thirty-eight (55.1%) subjects 
had liver steatosis, with el-
evated ALT in 27 (71.1%) of them
Caserta et al. 
(2010) (47)
Italy 642 adolescents aged 
11-13 y
To determine the preva-
lence of NAFLD
NAFLD was found in 12.5% of 
participants, increasing to 
23.0% in overweight ones. 
Increased IMT wasassociated 
with NAFLD
Nobili et al. 
(2010) (54)
Italy 118 children with biopsy-
proven NAFLD
To assess the association 
of severity of liver injury 
and lipid proﬁle
The NAFLD activity and ﬁbrosis 
scores had positive correlation 
with triglyceride/HDL, total 
cholesterol/HDL, and LDL/HDL 
ratios
Patton et al.
(2010) (56)
USA 254 children aged 6-17 y To determine the as-
sociation of metabolic 
syndrome with NAFLD
65 (26%) had metabolic 
syndrome with greatest risk 
among those with severe 
steatosis; hepatocellular bal-
looning was associated with 
metabolic syndrome
Shi et al.
(2009) (60)
China 308 obese children aged 
9 to 14 y
To determine the preva-
lence of NAFLD and 
metabolic syndrome
Among all the obese children, 
the prevalence of NAFLD, NASH 
and  metabolic syndrome was 
65.9% , 20.5% and 24.7% respec-
tively
Koebnick et al. 
(2009) (51)
USA Hospitalized with  
NAFLD or obesity in 
6-25 y
To investigate trends 
of NAFLD and obesity 
among hospitalized 
patients
Between 1986 to 1988 and 2004 
to 2006, hospitalization in-
creased from 0.9 to 4.3/100,000 
for NAFLD, and from 35.5 to 
114.7/100,000 for obesity
Reinehr et al.
(2009) (57)
Germany Obese children  fol-
lowed for 1 y
To determine the course 
of obesity associated 
NAFLD
20.6% of obese children had 
hypertension, 22.3% had dys-
lipidemia, 4.9% had impaired 
fasting glucose , and 29.3% had 
NAFLD
Denzer et al. 
(2009) (26) 
Germany 532 obese subjects aged 
8–19 y
To examine the preva-
lence and markers as-
sociated with NAFLD
Hepatic steatosis was higher in 
boys (41.1%) than in girls (17.2%) 
and was highest in postpuber-
tal boys (51.2%) and lowest in 
postpubertal girls (12.2%)
Sharp et al.
(2009) (59)
U.S.-Mexico border 31 patients aged 8-18 y To describe the physical 
and metabolic char-
acteristics of children 
diagnosed with NAFLD
The majority of cases were ado-
lescents (12-17 y) and Mexican 
American. All subjects were 
overweight
Fu et al.
(2009) (48)
Taiwan 220 students (97normal, 
48overweight,75obese) 
12y
To investigate the 
risk factors for NAFLD 
among adolescents 
NAFLD was detected in 39.8% in 
total, 16.0% in normal ,50.5% in 
overweight, and 63.5% among 
obese adolescents
Rocha et al. 
(2009) (58)
Brazil 1801 children aged 11 
to 18 y
To evaluate the preva-
lence and clinical char-
acteristics of NAFLD
The prevalence of NAFLD was 
2.3%, most of whom were male 
and white. Insulin resistance 
(IR) was observed in 22.9% of 
them
Table. Summary of Studies on the Prevalence of Pediatric Non-alcoholic Fatty Liver Disease797
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obese children and adolescents, ranging from 10% to 25% 
based on elevated ALT, compared with 42% to 77% based 
on ultrasonography (41-44). Table provides a summary of 
prevalence studies on pediatric NAFLD (25, 26, 39, 40, 45-63). 
6. NAFLD or MAFLD?
Because of the well-documented interrelationships be-
tween the risk factors, metabolic alterations, and liver 
histology of NAFLD and metabolic syndrome, a recent 
review suggested the term MAFLD (metabolic syndrome-
associated fatty liver disease), which might describe both 
groups of patients with common pathophysiological fea-
tures more accurately (64). A growing body of evidence 
proposes that NAFLD and metabolic syndrome are inter-
related even from childhood. Many studies revealed that 
the components of the metabolic syndrome are strong 
predictors of increased ALT activity in NAFLD among chil-
dren and adolescents (42, 65-71). It is also documented 
that the higher levels of components of metabolic syn-
drome increase the risk of elevated ALT or AST in children 
and adolescents (50). 
7. Pediatric NAFLD and Early Atherosclero-
sis
NAFLD shares the same causal factors with metabolic 
syndrome, which are also major cardiovascular risk fac-
tors. While there are conﬂicting results about the asso-
ciation of NAFLD with atherosclerotic cardiovascular 
diseases (72), a review of some studies conﬁrmed the pro-
atherogenic role of NAFLD, and suggested that among 
adult populations it can be an independent risk factor 
for atherosclerotic cardiovascular diseases (73). How-
Graham et al. 
(2009) (49)
US A Sample of 12-19 y from 
the NHANES1999 to 
2002
To determine the as-
sociation of metabolic 
syndrome and NAFLD
The metabolic syndrome was 
associated with ALT > 40 U/L 
(OR = 16.7, CI 6.2-45.1)
Carter-Kent et al. 
(2009) (46)
USA 130 children with 
biopsy-proven NAFLD
To assess clinical and 
laboratory predictors of 
NAFLD severity
Fibrosis was present in 87% 
of patients; of these, stage 3 
(bridging ﬁbrosis) was present 
in 20%
Alavian et al. 
(2009) (45)
Iran 966 children aged 7-18 y To investigate the preva-
lence of NAFLD
Fatty liver was diagnosed by 
ultrasound in 7.1% of children. 
The prevalence of elevated ALT 
was 1.8%
Kelishadi et al. 
(2009) (50) 
Iran 1107 children aged 6-18 y To compare the preva-
lence of NAFLD in diﬀer-
ent BMI categories
Elevated ALT was documented 
in respectively 4.1of normal 
weight, 9.5%in overweight and 
16.9% in obese group, respec-
tively
Fraser et al.
(2007) (40)
USA NHANES participants, 
aged 12-19 y (1999–2004)
To determine the preva-
lence of NAFLD
a prevalence of NAFLD of 8% 
based on elevated ALT
Schwimmer et al. 
(2006) (39)
USA 742 children aged 2-19 y 
with autopsy 
To determine the preva-
lence of biopsy-proven 
NAFLD
Fatty liver was present in 13% of 
subjects. ranging from 0.7% for 
ages 2 to 4 up to 17.3% for ages 
15 to 19 y
Schwimmer et al. 
(2005) (25)
USA 127 obese 12th-grade 
students
To determine the preva-
lence of NAFLD
Unexplained ALT elevation was 
present in 23% of participants , 
in boys (44%) and in girls (7%)
Park et al.
(2005) (55)
Korea  1594 children aged 
10-19 y
To investigated the rela-
tion of NAFLD and the 
metabolic syndrome 
The prevalence of elevated ALT 
(> 40 U/L) was 3.6% in boys and 
2.8% in girls. The prevalence of 
metabolic syndrome was 3.3% 
in both boys and girls
Strauss et al.
(2000)(61)
USA 2450 children aged 
12-18 y
To determine the preva-
lence of NAFLD in diﬀer-
ent BMI categories
6% of overweight adolescents 
had elevated ALT levels; about 
1% of obese adolescents had ALT 
levels over twice normal
Tominaga et al. 
(1995) (62)
Japan  810 students, ages 4-12 y To determine the preva-
lence of NAFLD
The overall prevalence of 
NAFLD was 2.6%., boys (3.4%) 
and girls (1.8%), (P = 0.15)
Sharp et al.
(2009) (56)
USA-Mexico  31 patients aged 8-18 y To describe the char-
acteristics of children 
diagnosed with NAFLD
The majority of children 
were aged 12-17 y and Mexican 
American. All subjects were 
overweight
a Abbreviations: ALT, alanine aminotransferase; NAFLD; non-alcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis798
Hepat Mon. 2011;11(10):794-802
Obesity and Air Pollution Kelishadi R et al.
ever, a review of some other studies suggested that in 
spite of the existing association of NAFLD with the early 
onset of the metabolic and vascular pathogenic changes 
of atherosclerosis, the evidence for the relationship be-
tween NAFLD and cardiovascular diseases is weak (74). 
A population-based cohort study of adults, aged 30–70 
years, showed that the carotid-intima media thickness 
(C-IMT) values were strongly correlated with metabolic 
syndrome factors. No signiﬁcant diﬀerence in C-IMT was 
found between patients with isolated NAFLD and in con-
trols, whereas in patients with NAFLD associated with 
metabolic syndrome, the C-IMT values were signiﬁcantly 
higher than those in patients with NAFLD alone. This 
study revealed a possible independent role of NAFLD in 
determining arterial stiﬀness, assessed by measuring the 
values of carotid-femoral pulse wave velocity (75). Recent 
studies of children and adolescents conﬁrmed the asso-
ciation of NAFLD with C-IMT, and suggested that the liver 
and blood vessels share common mediators (47, 50, 76, 
77). The clinical importance of the associations of NAFLD 
with C-IMT in children and adolescents need to be con-
ﬁrmed through longitudinal studies.
8. Dietary and Physical Activity Habits Re-
lated to Pediatric NAFLD
There is a growing body of evidence about the signiﬁ-
cance of environmental background in the establish-
ment and development of NAFLD from the early years of 
life. Unhealthy dietary habits, such as disproportionately 
high consumption of saturated fats and reﬁned sugars, 
may harm adipose tissue architecture and homeostasis. 
They may also alter the peripheral and hepatic resis-
tance to insulin-stimulated glucose uptake, thus favor-
ing chronic low-grade inﬂammation. Excess nutrients 
that cannot be stored in adipose tissue would overﬂow 
to muscle tissue and the liver. Fat deposition in both 
sites increases insulin resistance and promotes further 
fat deposition (78, 79). Lifestyle, notably dietary habits, 
is associated with the development of NAFLD (80). The 
diet most recommended for prevention and control of 
NAFLD is a low-carbohydrate diet, with a very limited 
amount of reﬁned carbohydrates (81, 82). In our study of 
adolescents aged 12–18 years we found signiﬁcant associa-
tions between insulin resistance and NAFLD, and similar 
risk factors and protective factors for these 2 interrelated 
disorders. Waist circumference and the ratio of apolipo-
protein B to apolipoprotein A-I (ApoB/ApoA-I ratio) had 
the highest odds ratio (OR) in increasing the risk of in-
sulin resistance and NAFLD, whereas cardiorespiratory 
ﬁtness, followed by healthy eating index, decreased this 
risk signiﬁcantly (50). 
9. Environmental Factors Related to NAFLD
9.1. Smoking and NAFLD
A growing body of evidence supports the potential ef-
fects of exposure to some environmental factors on liver 
diseases. Environmental exposure related to toxic waste 
sites was associated with an increased prevalence of au-
toimmune liver disease (83, 84). Therefore, increasing 
attention is being given to the eﬀects of environmental 
factors on liver diseases, including NAFLD. Many recent 
studies have also documented the association of smok-
ing with the incidence of and acceleration of disease 
progression in NAFLD, as well as with advanced ﬁbrosis 
in this process (85-89).
9.2. Air Pollution and NAFLD
The harmful eﬀects of air pollutants on atherosclerotic 
cardiovascular diseases are well-documented (88). These 
eﬀects might be mediated through oxidative stress and 
insulin resistance (90), which are also known to have piv-
otal roles in the pathogenesis of fatty liver (91). Hence, it 
can be assumed that such environmental factors might 
be also associated with NAFLD. It is well-documented 
that d    iesel exhaust particles (DEP), which are major con-
stituents of atmospheric particulate matters (PM) in ur-
ban areas, generate reactive oxygen species (ROS) (92). 
The ROS are generated via enzymatic reactions catalyzed 
by cytochrome P-450 (93), or by a non-enzymatic route 
(94). In 2007, two experimental studies examined the ef-
fects of exposure to DEP on fatty liver for the ﬁrst time. 
One of these studies revealed that exposure to DEP might 
increase oxidative stress, with concomitant aggravation 
of fatty changes in the livers of diabetic obese mice. This 
exposure increases the AST and ALT levels, liver weight, 
and the degree of fatty change of the liver, as ascertained 
histologically. This study suggested that ROS, lipid perox-
ides, or inﬂammatory cytokines produced in the lungs 
might reach the liver, or soluble constituents of PM 
might get transferred from the lung to the liver through 
systemic circulation. Given that exposure to these par-
ticles may decrease the mitochondrial membrane poten-
tial, and may increase ROS, followed by cytochrome-c re-
lease and inner mitochondrial membrane damage, this 
study proposed that mitochondrial damage could have 
an enhancing eﬀect on NAFLD, especially in augmenting 
the eﬀects of oxidative stress on the liver (95). The oth-
er experimental study assessed the eﬀects of oxidative 
stress elicited by DEP in the aorta, liver, and lungs of dys-
lipidemic ApoE(-/-) mice, at the age when visual plaques 
appeared in the aorta. Vascular eﬀects secondary to pul-
monary inﬂammation were omitted by injecting DEP 
into the peritoneum. Six hours later, the expression of 
inducible nitric oxide synthase (iNOS) mRNA increased 
in the liver. Injection of DEP did not induce inﬂamma-
tion or oxidative damage to DNA in the lungs and aorta. 
Therefore, the study proposed a direct eﬀect of DEP on in-
ﬂammation and oxidative damage to DNA in the liver of 
dyslipidemic mice (96). 
Another study investigated the eﬀects of a 6-week-
exposure to ﬁltered air, in comparison with ambient 
air PM at doses mimicking naturally occurring levels, 
on diet-induced hepatic steatosis in mice fed high-fat 
diets. Progression of NAFLD was evaluated by histologi-799
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cal examination of hepatic inﬂammation and ﬁbrosis. 
This study showed that ambient PM reaches the liver 
by crossing the alveolar membranes and passing into 
circulation. Circulating ﬁne PM may then accumulate 
in hepatic Kupﬀer cells, and has the potential to induce 
Kupﬀer cell cytokine secretion, which in turn triggers 
inﬂammation and collagen synthesis in hepatic stellate 
cells (97). It is noteworthy that interleukin-6, the con-
centration of which increased up to 7-fold in the above-
mentioned study, is also signiﬁcantly abundant in cases 
of human NAFLD (98). Some human studies conﬁrmed 
the harmful eﬀects of environmental toxins on liver dis-
eases. For instance, it has been reported that non-obese 
chemical workers highly exposed to vinyl chloride may 
develop insulin resistance and toxicant-associated ste-
atohepatitis (99). Limited data exists on the potential 
role of environmental pollution on liver disease in the 
general population. A large population-based study was 
conducted on 4582 adult participants without viral hep-
atitis, hemochromatosis, or alcoholic liver disease, from 
the National Health and Nutrition Examination Survey 
(NHANES) in 2003-2004, to investigate whether environ-
mental pollutants are associated with an elevation in se-
rum ALT and suspected NAFLD. The ORs for ALT elevation 
were determined across exposure quartiles for 17 pollut-
ants, after adjustments for age, race/ethnicity, sex, body 
mass index, poverty income ratio, and insulin resistance. 
It showed that exposure to polychlorinated biphenyls as 
well as heavy metals, notably lead and mercury, was as-
sociated with unexplained ALT elevation, and increased 
adjusted ORs for ALT elevation in a dose-dependent man-
ner (100). Given the susceptibility of children and adoles-
cents to the harmful eﬀects of air pollutants, including 
their eﬀects on oxidative stress and insulin resistance 
documented even in moderate levels of air pollution 
(101), similar eﬀects of air pollutants on pediatric NAFLD 
can be expected.
In addition, a growing number of studies suggest that 
air pollution can aggravate the adverse eﬀects of obesity 
and insulin resistance. As cited in the statements of the 
American Heart Association (86), our study among Ira-
nian children and adolescents provided the ﬁrst biologi-
cal evidence for the association of air pollutant-induced 
systemic pro-inﬂammatory and oxidative responses 
with metabolic syndrome (101). Similarly, a study in Can-
ada revealed that long-term traﬃc exposure (NO2 level, 
by residence) was associated with a nearly 17% increase 
in the risk of having diabetes mellitus (102). Similarly, 
some other studies have documented the association of 
exposure to air pollutants with metabolic syndrome, as 
well as susceptibility to diabetes mellitus and aggrava-
tion of its complications (103-105). Given the inﬂamma-
tory and oxidative properties of air pollutants, as well as 
their association with insulin resistance and metabolic 
syndrome, and considering the interaction of the lat-
ter conditions with fatty changes in liver, more studies 
about the eﬀects of environmental factors, notably air 
pollution, on NAFLD are warranted. The high susceptibil-
ity of the pediatric age group to the harmful eﬀects of air 
pollutants, especially pertaining to early stages of chron-
ic diseases (22, 50, 106-108), further stresses that more at-
tention should be given to preventing late-onset eﬀects 
of air pollutants.
10. Conclusion
The prevalence of childhood obesity and air pollution 
is dramatically increasing on a global scale. Given that 
both excess body fat and exposure to air pollutants are 
accompanied by systemic low-grade inﬂammation, oxi-
dative stress as well as alterations in insulin/insulin-like 
growth factor and insulin resistance, which contribute to 
fatty liver, an escalating trend in the incidence of pediat-
ric NAFLD and its related complications can be expected 
in the near future. Studying the underlying mechanisms 
and broadening eﬀorts to prevent and control the 2 main 
universal risk factors, obesity and air pollution, which 
have broad adverse health eﬀects, will help abate the se-
rious health problems associated with pediatric NAFLD.
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